|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Ceapro Inc., of Edmonton, Alberta, raised C$645,400 (US$467,775) after selling royalty income units comprised of one common share at an issuance price of 26 cents, one common share purchase warrant with an exercise price of 36 cents if exercised prior to Aug. 31 and an exercise price of 56 cents if exercised thereafter until Dec. 31, and a royalty interest unit at an issuance price of $1.04 entitling the owner to a share of royalties from product sales. The company, which develops natural products for the medical and animal health industries, said its plans to introduce its animal health products in North America and launch AccuScreen, its diabetes screening test.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Expert reviews treatment options for CA-MRSA.(INFECTIOUS ...
Pediatric News;
May 1, 2009 ;
700+ words
...SAN DIEGO -- Clindamycin and trimethoprim-sulfamethoxazole are ... taste too bad,'" said Dr. Pong of the division of infectious diseases at Rady Children's Hospital, San Diego. However, it's not effective for group A streptococci ...
|
|